GHUCCTS

News

Share This
  • May 01, 2020

NIH awards $24M to GHUCCTS to support clinical and translational research

WASHINGTON (May 1, 2020) - The Georgetown-Howard Universities Center for Clinical and Translational Science (GHUCCTS) has received a $24.3 million Clinical and Translational Science Award from the National Center for Advancing Translational Science, a part of the National Institutes of Health.

The competitive renewal represents the third 5-year award for the center, which has secured $89.8 million in research funding over 15-years for its member institutions: Georgetown University, Howard University, MedStar Health Research Institute, the Washington DC Veterans Affairs Medical Center and Oak Ridge National Laboratory.

Led by principal investigators Joseph Verbalis, MD, from Georgetown University and Thomas Mellman, MD, from Howard University, the mission of GHUCCTS is to advance research and training with excellence, innovation, collaboration, and efficiency while realizing the potential of the unique capacities of its constituent institutions for developing new technologies, promoting ethical clinical and translational research, and engaging the diverse populations of our communities that have been historically underrepresented in clinical research, including people from diverse racial, ethnic, and cultural backgrounds, people with disabilities, and older adults.

“One of the major missions of GHUCCTS has been to stimulate and support the growth of team science,” says Verbalis, a professor of medicine at Georgetown. “Advances in solving the complex and challenging health problems we face today can be achieved more quickly and efficiently by collaborations among investigators from different scientific disciplines working together on common problems.”

“GHUCCTS was built on a unique model of co-leadership between Georgetown and Howard University, a Historically Black University,” says Mellman, a professor of psychiatry at Howard. “The partnership has influenced prioritizing health disparities and diversity in our training and research missions. Diversity of institutional cultures and of the disciplines represented in our programs has been a founding and enduring strength of GHUCCTS.” 

As one of 60 national CTSA programs, GHUCCTS has transformed research in the greater Washington DC region. Verbalis and Mellman along with faculty members from all of the GHUCCTS institutions and numerous collaborators across the region have achieved impressive goals over the last 10 years, including:

With this new award, GHUCCTS will continue to develop and promote innovative clinical and translational science research to improve the health of the greater Washington DC population.

Download PDF

Related News

Deadline Extended: 2021 KL2 Scholars Program Application

Jan 05, 2021

The Georgetown-Howard Universities Center for Clinical and Translational Science (GHUCCTS) is now accepting applications for our 2021 KL2 Scholars Program. The pre-application is due January 31, 2021 with the final application due February 28, 2021. Funding is expected to begin in June 2021 pending the evolution of the COVID-19 pandemic.

Two GHUCCTS advisors named to NIH ACTIV-1 Community Advisory Board

Dec 17, 2020

We are proud to share that two of our advisors have been named to the Community Advisory Board (CAB) for the National Institutes of Health Accelerating COVID-19 Therapeutics Interventions and Vaccines (ACTIV) initiative. Robert Pearson, a member of our Participant Advisory Board (PAB), and Larisa Caicedo, a member of our own CAB, will advise on the ACTIV-1 protocol.

NHCOA honors Florencia Gonzalez with Research Recognition Award

Dec 11, 2020

On Tuesday December 15, 2020, the National Hispanic Council on Aging (NHCOA) will honor Florencia Gonzalez as a 2020 recipient of the NHCOA Award. The virtual ceremony, called A Time for Change, will recognize leaders in the field of aging who share NHCOA’s commitment to Hispanic older adults.

Close